Skip to contentB
BIO-TECHNE Corp
B
TECHBIO-TECHNE Corp Q1 2024 · 10-Q
Revenue$276.94M$276.94M+2.7% vs Q1 2023 Net Income$50.99M$50.99M−43.1% vs Q1 2023 EPS Diluted$0.31$0.31−43.6% vs Q1 2023 Gross Profit$185,191,000+3.1% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
BIO-TECHNE Corp · CIK 842023 · Engraved from SEC EDGAR
Operating Cash Flow$59,383,000+5.9% Free Cash Flowderived$45,791,000−1.6% Margins · derivedGross margin66.9%+0.3 pt vs Q1 2023
Operating margin20.2%−0.7 pt vs Q1 2023
Net margin18.4%−14.8 pt vs Q1 2023
ended Sep 30, 2023 · filed Nov 7, 2023 · 38 d after period end